35
Views
9
CrossRef citations to date
0
Altmetric
Clinical Focus: Metabolic Syndrome and Related Conditions

Physicians' Attitudes Toward Post-MI Aspirin Prophylaxis: Findings from an Online Questionnaire in Europe and Latin America

, MD, FAHA, , BA & , MD, PhD, MPH
Pages 44-53 | Published online: 13 Mar 2015

References

  • . American Stroke Association/American Heart Association. Heart Disease and Stroke Statistics—2005 Update. 2005:1–60
  • . Adabag AS, Therneau TM, Gersh BJ, . Sudden death after myocardial infarction. JAMA. 2008;300(17):2022–2029
  • . Tribouilloy C, Buiciuc O, Rusinaru D, Malaquin D, Lévy F, Peltier M. Long-term outcome after a first episode of heart failure. A prospective 7-year study [published online ahead of print December 17, 2008]. Int J Cardiol.
  • . Becker RC, Meade TW, Berger PB, . American College of Chest Physicians. The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133( 6 suppl):776S–814S
  • . Graham I, Atar D, Borch-Johnsen K, . European Society of Cardiology (ESC); European Association for Cardiovascular Prevention and Rehabilitation (EACPR); Council on Cardiovascular Nursing; et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur Journal of Cardiovasc Prev Rehabil. 2007;14( suppl 2):E1–E40
  • . US Preventive Services Task Force. Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;150(6):396–404
  • . ; Antithrombotic Trialists' (ATT) CollaborationBaigent C, Blackwell L, Collins R, . Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373(9678):1849–1860
  • . The aspirin myocardial infarction study: final results. The Aspirin Myocardial Infarction Study research group. Circulation. 1980;62(6 pt 2):V79–V84
  • . Baigent C, Collins R, Appleby P, Parish S, Sleight P, Peto R. ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. BMJ. 1998;316(7141):1337–1343
  • . Breddin K, Loew D, Lechner K, Uberla K, Walter E. Secondary prevention of myocardial infarction: a comparison of acetylsalicylic acid, placebo and phenprocoumon. Haemostasis. 1980;9(6):325–344
  • . Elwood PC, Cochrane AL, Burr ML, . A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction. Br Med J. 1974;1(5905):436–440
  • . Elwood PC, Sweetnam PM. Aspirin and secondary mortality after myocardial infarction. Lancet. 1979;2(8156–8157):1313–1315
  • . Elwood PC, Williams WO. A randomized controlled trial of aspirin in the prevention of early mortality in myocardial infarction. J R Coll Gen Pract. 1979;29(204):413–416
  • . Hennekens CH, Schneider WR. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease. Expert Rev Cardiovasc Ther. 2008;6(1):95–107
  • . Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group. Circulation. 1980;62(3):449–461
  • . Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324(7329):71–86
  • . Burwen DR, Galusha DH, Lewis JM, . National and state trends in quality of care for acute myocardial infarction between 1994–1995 and 1998–1999: the medicare health care quality improvement program. Arch Intern Med. 2003;163(12):1430–1439
  • . Abdallah MH, Arnaout S, Karrowni W, Dakik HA. The management of acute myocardial infarction in developing countries. Int J Cardiol. 2006;111(2):189–194
  • . Reaume KT, Regal RE, Dorsch MP. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use. Ann Pharmacother. 2008;42(4):550–557
  • . Toth PP. The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes. Postgrad Med. 2009;121(1):59–72
  • . van den Bergh PJ, Kievit PC, Brouwer MA, Aengevaeren WR, Veen G, Verheugt FW. Prolonged anticoagulation therapy adjunctive to aspirin after successful fibrinolysis: from early reduction to reocclusion to improved long-term clinical outcome. Am Heart J. 2009;157(3):532–540
  • . Sacco RL, Adams R, Albers G, . American Heart Association/American Stroke Association Council on Stroke; Council on Cardiovascular Radiology and Intervention; et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Circulation. 2006;113(10):e409–e449
  • . Cotter G, Shermesh E, Zehavi M, . Lack of aspirin effect: aspirin resistance or resistance to taking aspirin? Am Heart J. 2004;147(2):293–300
  • . Choudhry NK, Patrick AR, Antman EM, Avorn J, Shrank WH. Cost-effectiveness of providing full drug coverage to increase medication adherence in post-myocardial infarction Medicare beneficiaries. Circulation. 2008;117(10):1261–1268
  • . Moran A, Goldman L. Eliminating out-of-pocket drug costs may improve outcomes after myocardial infarction–but at what cost to Medicare? Nat Clin Pract Cardiovasc Med. 2008;5(10):606–607
  • . Choudhry NK, Brennan T, Toscano M, . Rationale and design of the Post-MI FREEE trial: a randomized evaluation of first-dollar drug coverage for post-myocardial infarction secondary preventive therapies. Am Heart J. 2008;156(1):31–36
  • . Roth A, Malov N, Steinberg DM, . Telemedicine for post-myocardial infarction patients: an observational study. Telemed J E Health. 2009;15(1):24–30

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.